Canada markets open in 8 hours 14 minutes

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.5700-0.0156 (-2.66%)
At close: 04:00PM EST
0.5800 +0.01 (+1.75%)
After hours: 05:50PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 34.24M
Enterprise Value -27.90M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.45
Price/Book (mrq)0.56
Enterprise Value/Revenue -4.03
Enterprise Value/EBITDA 0.32

Trading Information

Stock Price History

Beta (5Y Monthly) 1.82
52-Week Change 3-89.70%
S&P500 52-Week Change 315.03%
52 Week High 37.5500
52 Week Low 30.5600
50-Day Moving Average 31.0422
200-Day Moving Average 33.4568

Share Statistics

Avg Vol (3 month) 31.04M
Avg Vol (10 day) 31.29M
Shares Outstanding 531.41M
Implied Shares Outstanding 6N/A
Float 821.82M
% Held by Insiders 15.74%
% Held by Institutions 160.93%
Shares Short (Dec. 30, 2021) 4241.56k
Short Ratio (Dec. 30, 2021) 40.2
Short % of Float (Dec. 30, 2021) 40.77%
Short % of Shares Outstanding (Dec. 30, 2021) 40.77%
Shares Short (prior month Nov. 29, 2021) 4343.85k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb. 12, 2017
Ex-Dividend Date 4Aug. 19, 2015
Last Split Factor 21:15
Last Split Date 3Feb. 12, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,247.25%

Management Effectiveness

Return on Assets (ttm)-56.76%
Return on Equity (ttm)-111.78%

Income Statement

Revenue (ttm)6.93M
Revenue Per Share (ttm)0.25
Quarterly Revenue Growth (yoy)157.40%
Gross Profit (ttm)-40.39M
EBITDA -86.2M
Net Income Avi to Common (ttm)-86.51M
Diluted EPS (ttm)-3.0550
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)64.53M
Total Cash Per Share (mrq)2.05
Total Debt (mrq)2.39M
Total Debt/Equity (mrq)3.94
Current Ratio (mrq)4.29
Book Value Per Share (mrq)1.93

Cash Flow Statement

Operating Cash Flow (ttm)-88.19M
Levered Free Cash Flow (ttm)-56.27M